- The company just reported its latest quarterly result with record sales and earnings benefiting from strong demand in animal health diagnostics.
- The growing installed base of premium testing equipment is driving the recurring sales of high-margin specialty consumables.
- Management revised higher its 2021 earnings guidance supporting a positive momentum in the stock.
- Shares are pricey, but we believe the company deserves its valuation premium as it consolidates its leadership position.
For further details see:
IDEXX Laboratories: An Impressive Earnings Growth Story